Abstract CT290: Trial in progress: Evaluation of the safety, tolerability, whole-body distribution, radiation dosimetry and antitumor activity of 177Lu-NeoB in patients with advanced solid tumors expressing gastrin-releasing peptide receptor (GRPR)
已取消20由 Lilian 发布于 2025/10/21 14:30:15
DOI:10.1158/1538-7445.am2024-ct290
作者:Erik S. Mittra, Andrei Iagaru, A. V. D. van der Veldt, Luigi Aloj, Jeffrey Wong, L. Djaileb, Dhrubajyoti Pathak, Yongmin Liu, L. Solnes
文献类型:期刊论文
补充材料:只需要正文 管理员驳回:超时未应助,系统关闭。如求助信息不完整(标题、DOI、原文链接),可以补充后重新发布求助。